MLchartDataset catalogue

modafinil

Term · Oncology and biomedicine · MLC-T-ONC-005448

  1. A drug that is being studied as a treatment for fatigue in patients with cancer. It belongs to the family of drugs called stimulants.

  2. A synthetic central nervous system stimulant with wakefulness-promoting activity. Modafinil appears to inhibit dopamine reuptake, resulting in an increase in extracellular dopamine. This agent exhibits pronounced wakefulness-promoting activity (without sympathomimetic activity) and may improve cognitive function in certain clinical settings.

Table 1. Record
IdentifierMLC-T-ONC-005448
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-005448",
  "term": "modafinil",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A drug that is being studied as a treatment for fatigue in patients with cancer. It belongs to the family of drugs called stimulants.",
    "A synthetic central nervous system stimulant with wakefulness-promoting activity. Modafinil appears to inhibit dopamine reuptake, resulting in an increase in extracellular dopamine. This agent exhibits pronounced wakefulness-promoting activity (without sympathomimetic activity) and may improve cognitive function in certain clinical settings."
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/modafinil/"
}

Record 11,159 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.